Invion Limited (ASX:IVX) Reports Positive Phase I/II Skin Cancer Trial Results
Invion Limited (ASX:IVX) reports positive safety and efficacy results in Phase I/II skin cancer trial, progressing to next study phase.
Category: ASX-IVX
Invion Limited
Latest News
Axel REE Limited (ASX:AXL) Announces Strategic Leadership Transition
Lunnon Metals (ASX:LM8) Reveals New Gold Structures in Sterilisation Drilling
Merchant House International Limited (ASX:MHI) Announces Preliminary Financial Results for FY2025
New Zealand King Salmon Investments Limited (ASX:NZK) Reduces FY26 Harvest Volumes
Invion Limited (ASX:IVX) Reports Positive Phase I/II Skin Cancer Trial Results
Noxopharm Limited (ASX:NOX) Receives Approval for HERACLES Clinical Trial
Bayan Mining and Minerals (ASX:BMM) Initiates Phase Two Exploration at Bayan Springs Project
St Barbara Limited (ASX:SBM) Confirms 15-Mile Processing Hub Development
ikeGPS Group Limited (ASX:IKE) Announces FY25 Financial Results
Emyria Limited (ASX:EMD) Reports Promising Six-Month PTSD Outcomes and MOU with ANU
The Hub of Australian Finance News